Peripartum Cardiomyopathy Registry Biomarker sub-protocol

Peripartum Cardiomyopathy Registry Biomarker sub-protocol - PPCM Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43678

Enrollment

Registered

2016-04-01

Start date

2015-12-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripartum cardiomyopathy pregnancy related heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with peripartum cardiomyopathy 1. peripartum stage 2. Signs and/or symptoms of heart failure 3. Ejection fraction

Exclusion criteria

Exclusion criteria: Other cause of heart failure

Design outcomes

Primary

Measure	Time frame
The primary objective of this registry is to describe the epidemiology and prognosis of outpatients and inpatients with PPCM and the diagnostic and therapeutic processes.	—

Secondary

Measure	Time frame
The registry will serve to identify parameters that serve as diagnostic and prognostic markers* these may be useful for identification and risk stratification. Biomarkers such as NT-proBNP, Soluble ST2, Galectin -3, metalloproteinases, C-reactive protein and other biomarkers that may arise to be potentially important during the execution of this study, will be evaluated.	—

Countries

Netherlands

Outcome results